Skip to content

State of community oncology: 2023 in review and looking ahead to 2024


February 2024

State of community oncology: 2023 in review and looking ahead to 2024

In this discussion, an incredible panel of community oncology leaders explore the latest trends and care, reimbursement, technology and policy that will shape the landscape of community oncology in 2024 and beyond.

State of community oncology

Watch this video to:

  • Unpack the significance of Medicare Advantage for oncology, and what practice leaders should be thinking about headed into next year

  • Understand how practice leaders are optimizing around the latest care-navigation reimbursement codes and pursuing a more value-based approach to cancer care

  • Learn how practice leaders are exploring applications for Artificial Intelligence at their practices to alleviate the burden on operational and clinical teams  

More about the speakers:

  • Nina Chavez, VP of Strategic Partnerships & Alliances, Flatiron Health (Moderator)

  • Olalekan Ajayi, Chief Operating Officer Highlands Oncology Group, President of Association of Community Cancer Centers

  • Barbara McAneny, MD, CEO, New Mexico Oncology Hematology Consultants

  • Barry Russo, CEO, The Center for Cancer and Blood Disorders

Learn more about our point of care solutions

Interested in seeing how Flatiron is helping to deliver a better patient experience, strengthening practice health, and closing the gap between care and research?